Six cautions drawn from real-world experience that could help you avoid some common commercial pitfalls when launching medical devices in Europe.view »
Given marketplace and regulatory challenges today, U.S. and European companies must decide where to begin their commercialization efforts.
Given the lengthy and unpredictable FDA regulatory pathway, a growing number of medical device companies are evaluating and executing international commercialization strategies.
Years of effort and millions of dollars go into developing and testing medical devices before they are ready for commercial launch.
Whether the driver is a lengthy and unpredictable FDA regulatory pathway or growth opportunities in emerging markets, a rising number of medical device companies are evaluating and executing international commercialization strategies.
Enterprise Ireland and the National University of Ireland, Galway hosts a seminar on “Winning Business in the U.S. Medical Device Market”.
Presentation and class discussion of health care system dynamics and real-world case studies for Japan, China and India.
The Global Center for Medical Innovation (GCMI) presents the opening session in the 2012 MedTech Innovation Education Series.
Industry experts discuss the pros and cons of commercialization in Europe at the annual Advanced Medical Technology Association (AdvaMed) meeting.